HK1053264A1 - Phosphonate analogues of mannose-6-phosphate and their use in the treatment of wounds and fibrotic disorders. - Google Patents

Phosphonate analogues of mannose-6-phosphate and their use in the treatment of wounds and fibrotic disorders.

Info

Publication number
HK1053264A1
HK1053264A1 HK03105420A HK03105420A HK1053264A1 HK 1053264 A1 HK1053264 A1 HK 1053264A1 HK 03105420 A HK03105420 A HK 03105420A HK 03105420 A HK03105420 A HK 03105420A HK 1053264 A1 HK1053264 A1 HK 1053264A1
Authority
HK
Hong Kong
Prior art keywords
wounds
mannose
phosphate
treatment
fibrotic disorders
Prior art date
Application number
HK03105420A
Other languages
English (en)
Inventor
Mark William James Ferguson
Sally Freeman
Sarah Glenys Moore
Original Assignee
Renovo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Renovo Ltd filed Critical Renovo Ltd
Publication of HK1053264A1 publication Critical patent/HK1053264A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • C07H11/04—Phosphates; Phosphites; Polyphosphates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK03105420A 1995-08-04 2003-07-28 Phosphonate analogues of mannose-6-phosphate and their use in the treatment of wounds and fibrotic disorders. HK1053264A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9516012.3A GB9516012D0 (en) 1995-08-04 1995-08-04 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
HK1053264A1 true HK1053264A1 (en) 2003-10-17

Family

ID=10778773

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03105420A HK1053264A1 (en) 1995-08-04 2003-07-28 Phosphonate analogues of mannose-6-phosphate and their use in the treatment of wounds and fibrotic disorders.

Country Status (14)

Country Link
US (1) US6140307A (es)
EP (2) EP0841931B1 (es)
JP (2) JPH11510179A (es)
AT (2) ATE298579T1 (es)
AU (1) AU719992B2 (es)
CA (1) CA2229010C (es)
DE (2) DE69626987T2 (es)
DK (2) DK0841931T3 (es)
ES (2) ES2195000T3 (es)
GB (1) GB9516012D0 (es)
HK (1) HK1053264A1 (es)
PT (2) PT1291018E (es)
WO (1) WO1997005883A1 (es)
ZA (1) ZA966578B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2304047A (en) * 1995-08-09 1997-03-12 Univ Manchester Pharmaceutical compositions containing cytokines
GB2316002B (en) * 1996-08-12 1998-09-23 British Tech Group Mannose-6-phosphate composition and its use in treating fibrotic disorders
US6093388A (en) * 1996-08-12 2000-07-25 Btg International Limited Mannose-6-phosphate composition and its use in treating fibrotic disorders
AUPQ872300A0 (en) * 2000-07-11 2000-08-03 Praxis Pharmaceuticals Pty Ltd Compounds and methods
CA2525328C (en) * 2003-05-20 2012-07-31 Pharmaxis Pty Ltd. Novel phosphotetrahydropyrans and methods
US20080057072A1 (en) * 2006-08-31 2008-03-06 Alcon Manufacturing, Ltd. Antagonists of ci-m6p/igf2r for prevention and treatment of ctgf-mediated ocular disorders
WO2008144352A1 (en) * 2007-05-17 2008-11-27 Sunny Biodiscovery, Inc. Threitol phosphates, salts thereof and methods of use
GB0724231D0 (en) * 2007-12-12 2008-01-30 Renono Ltd Methods for inhibiting scarring
GB0910078D0 (en) 2009-06-11 2009-07-22 Renovo Ltd Uses of mannose-6-phosphate
GB0916334D0 (en) 2009-09-17 2009-10-28 Renovo Ltd Inhibition of tendon adhesions
GB0916332D0 (en) * 2009-09-17 2009-10-28 Renovo Ltd Medicaments
KR20210075068A (ko) 2018-08-10 2021-06-22 뉴욕 유니버시티 엔젤만 증후군 및 자폐증 치료를 위한 igf-2 수용체 작용제 리간드의 용도
AU2019320099A1 (en) * 2018-08-10 2021-04-01 New York University Use of mannose 6 phosphate and modifications thereof for memory enhancement and reducing memory impairment

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4703040A (en) * 1985-04-03 1987-10-27 Markov Angel K Treatment of adult respiratory distress syndrome (ARDS) using fructose diphosphate (FDP)
EP0429522B1 (en) * 1988-08-19 1996-06-26 The Australian National University Phosphosugar-based anti-inflammatory and/or immunosuppressive drugs
SE8904354D0 (sv) * 1989-12-21 1989-12-21 Matti Siren A pharmaceutical composition
GB9205800D0 (en) * 1992-03-17 1992-04-29 British Tech Group Treatment of fibrotic disorders
DK129293D0 (da) * 1993-11-16 1993-11-16 Carlsberg Lab Carbonhydratholdige forbindelser, der kan binde sig til carbonhydratbindende receptorer

Also Published As

Publication number Publication date
ATE298579T1 (de) 2005-07-15
PT841931E (pt) 2003-06-30
CA2229010A1 (en) 1997-02-20
US6140307A (en) 2000-10-31
JPH11510179A (ja) 1999-09-07
EP1291018B1 (en) 2005-06-29
JP2008239625A (ja) 2008-10-09
EP1291018A1 (en) 2003-03-12
ZA966578B (en) 1998-02-02
DK1291018T3 (da) 2005-09-12
DE69626987D1 (de) 2003-04-30
EP0841931B1 (en) 2003-03-26
ES2195000T3 (es) 2003-12-01
AU6624896A (en) 1997-03-05
EP0841931A1 (en) 1998-05-20
ES2243657T3 (es) 2005-12-01
ATE235245T1 (de) 2003-04-15
DE69634905D1 (de) 2005-08-04
WO1997005883A1 (en) 1997-02-20
DE69634905T2 (de) 2006-04-27
DK0841931T3 (da) 2003-04-22
PT1291018E (pt) 2005-08-31
DE69626987T2 (de) 2003-12-04
AU719992B2 (en) 2000-05-18
CA2229010C (en) 2009-06-02
GB9516012D0 (en) 1995-10-04

Similar Documents

Publication Publication Date Title
ZA966744B (en) Pharmaceutical composition.
AP1401A (en) Use of topiramate or derivatives thereof for the manufacture of a medicament for the treatment of manic- depressive bipolar disorder.
EP1140104A4 (en) METHOD OF INCREASING THE CYTIDINE MIRROR IN VIVO AND TREATING CYTIDINE-DEPENDENT HUMAN DISEASES
CA2130805A1 (en) Use of mannose phosphates for the treatment of fibrotic disorders
HK1053264A1 (en) Phosphonate analogues of mannose-6-phosphate and their use in the treatment of wounds and fibrotic disorders.
EP0892632A4 (en) AGENTS FOR USE IN PHOTOTHERAPEUTIC TREATMENT OF PROLIFERATIVE SKIN DISORDERS
EP1632248B8 (en) Anti-interleukin-9 antibody or anti-interleukin-9 receptor antibody for treating bronchial hyper-responsiveness
MX9703944A (es) Metodo para usar derivados de triaril-etileno en el tratamiento y prevencion de osteoporosis.
GB9521608D0 (en) Pharmaceutical composition
AU553269B2 (en) 2,3-diaryl-5-halo thiophenes
AU5986498A (en) Use of aminothiazoles for treating wounds and skin
DE59711240D1 (de) Verwendung von flupirtin zur therapie und prophylaxe von myokardinfarkt, schockniere und schocklunge
HUP9800272A3 (en) Use of penciclovir for the treatment of human herpes-virus-8
GB9614034D0 (en) Treatment of wounds
GB9812278D0 (en) Use of a wound dressing in the treatment of acute wounds
FI956064A0 (fi) Menetelmä haavojen paranemisen edistämiseksi ja tähän soveltuvia koostumuksia
ZA973538B (en) Use of phosphonic acid esters for the treatment of functional disorders of the brain and depression.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20120731